Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Lidocaine as Adjuvant to General Anesthesia
NCT03600493Phase 4Unknown
- Sponsor
- Suez Canal University
- Start
- Aug 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in Surgical stress response (2 arms), sponsored by Suez Canal University. Primary endpoint: Serum Interleukin 6. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
Surgical stress response
Beyond the preview
Go deeper on NCT03600493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03600493.